Straumann Holding AG

Straumann Holding AG

STMN · SW · Healthcare / Medical Instruments & Supplies

107.20CHF-0.05 (-0.05%)

Price History

Full chart

Market Stats

Previous Close107.25
Open107.65
Day Range106.80 – 107.85
52-Week Range72.22 – 109.80
Volume324.05K
Market Cap14.83B
P/E (TTM)40.26
Forward P/E26.11
EPS2.31
Dividend Yield1.09%
Beta1.36
50-Day Avg96.86
200-Day Avg93.80

About

Straumann Holding AG provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. It operates through Sales Europe, Middle East and Africa; Sales North America; Sales Asia Pacific; Sales Latin America; and Operations segments. The company offers dental implants, instruments, CADCAM prosthetics, orthodontic and clear aligners, biomaterials, and digital equipment and solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. It also provides implant systems, components, and related instruments, as well as healing components, materials and surfaces, surgical sets and instruments, and guided surgery and navigation products; prosthetics, including angled solutions, connections, components, and molar solutions; intra-oral and lab scanners, milling machines, dynamic navigation systems, and 3D printers; consumables, such as blocks, discs, resins, titanium bases, and abutment blanks, as well as scan bodies, analogs, and sleeves; online education; and dentists and dental labs solutions. In addition, the company offers regenerative solutions for tooth preservation, implant-site management, and implant preservation; scanner hardware, software licenses, sterile-packaged products, customer training, and other products; and logistics and supply chain services. Further, it provides thermoplastics; implant treatment referral; high-tech materials; artificial intelligence solutions for dental applications; and 3D orthodontic treatment animations. The company sells its products under the Straumann, Neodent, Medentika, Anthogyr, ClearCorrect, NUVO, and other brands through a network of distribution subsidiaries and partners, and third-party distributors, as well as through its e-shop. It serves clinicals needs, patient segments, and healthcare systems. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Guillaume Daniellot
  • Employees11.58K
  • HeadquartersPeter Merian-Weg 12, Basel, Switzerland, 4002, Switzerland
  • Websitehttps://www.straumann.com

Leadership

  • Mr. Guillaume DaniellotCEO, Interim Head of Dental Service Organizations & Member of Executive Management Board · b. 1970
  • Ms. Isabelle WegeCFO & Member of Executive Management Board · b. 1985
  • Mr. Kok-Kien LohRegional Head Asia Pacific & Member of the Executive Management Board · b. 1967
  • Mr. Holger HadererRegional Head of Europe, Middle East & Africa and Member of Executive Management Board · b. 1969
  • Mr. Sébastien RocheChief Operations & Supply Chain Officer and Member of Executive Management Board · b. 1972
  • Mr. Florian KirschHead of Integrated Dental Technologies & Member of Management Board · b. 1982
  • Mr. Andreas UtzHead of Implantology Business Unit (IBU) and Member of Executive Management Board · b. 1976
  • Ms. Sara DalmassoHead of the Dental Service Organization (DSO) and Member of Executive Management Board · b. 1977
  • Mr. Thomas FrieseChief Technology & Information Officer and Member of Executive Management Board · b. 1975
  • Mr. Alexei CostaExecutive VP of Latin America, President Neodent & Member of Executive Management Board · b. 1978

Financials

Income Statement

Currency: CHF2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue274.90M343.87M420.30M509.55M599.20M713.65M778.71M736.36M737.65M693.58M686.25M679.92M710.27M798.60M917.52M1.11B1.36B1.60B1.43B2.02B2.32B2.41B2.50B2.60B
Growth (%)-+25.09%+22.23%+21.24%+17.59%+19.10%+9.12%-5.44%+0.17%-5.97%-1.06%-0.92%+4.46%+12.44%+14.89%+21.21%+22.61%+17.06%-10.67%+41.80%+14.78%+3.92%+3.82%+4.04%
Cost of Revenue54.36M69.08M45.42M52.11M58.26M131.38M147.21M149.53M150.63M165.04M154.73M144.01M151.62M170.66M198.99M271.64M335.31M395.75M399.54M492.64M619.50M623.41M720.52M818.00M
Gross Profit220.53M274.79M374.87M457.44M540.94M582.27M631.50M586.83M587.02M528.54M531.52M535.91M558.65M627.94M718.53M840.46M1.03B1.20B1.03B1.53B1.70B1.79B1.78B1.79B
Gross Margin80.22%79.91%89.19%89.77%90.28%81.59%81.10%79.69%79.58%76.20%77.45%78.82%78.65%78.63%78.31%75.57%75.41%75.21%71.98%75.63%73.31%74.15%71.22%68.60%
Operating Expense145.77M175.56M247.91M301.50M365.62M380.76M591.10M421.50M422.71M448.62M470.51M420.99M410.84M442.85M491.70M557.54M676.89M800.14M710.02M992.76M1.17B1.38B1.18B1.25B
Operating Income74.76M99.23M126.97M155.94M175.32M201.51M40.41M165.34M164.31M79.92M61.01M114.92M147.81M185.09M226.83M282.92M351.36M400.33M316.30M536.51M530.49M410.97M601.00M537.93M
Operating Margin27.20%28.86%30.21%30.60%29.26%28.24%5.19%22.45%22.27%11.52%8.89%16.90%20.81%23.18%24.72%25.44%25.77%25.08%22.18%26.53%22.86%17.04%24.00%20.65%
EBITDA93.36M121.76M155.20M184.15M214.00M242.66M135.38M251.57M208.04M114.94M93.57M140.43M175.69M218.05M258.86M323.18M403.73M479.20M230.45M591.48M678.33M495.42M726.15M696.07M
EBITDA Margin33.96%35.41%36.93%36.14%35.71%34.00%17.39%34.16%28.20%16.57%13.63%20.65%24.74%27.30%28.21%29.06%29.61%30.02%16.16%29.25%29.23%20.54%29.00%26.72%
Net Income55.97M80.30M99.95M127.86M141.72M175.87M8.16M146.37M131.08M70.95M36.44M101.20M157.82M70.68M229.60M272.92M272.77M306.47M91.28M396.08M434.79M246.07M388.32M355.92M
Net Income Margin20.36%23.35%23.78%25.09%23.65%24.64%1.05%19.88%17.77%10.23%5.31%14.88%22.22%8.85%25.02%24.54%20.00%19.20%6.40%19.59%18.73%10.20%15.51%13.66%
R&D31.35M34.75M3.81M4.87M4.98M31.23M37.11M39.11M40.47M39.02M48.67M1.13M---2.02M6.15M6.20M128.56M96.00M104.60M111.10M115.90M-
R&D as % of Total Revenue11.41%10.11%0.91%0.96%0.83%4.38%4.77%5.31%5.49%5.63%7.09%0.17%---0.18%0.45%0.39%9.02%4.75%4.51%4.61%4.63%-
Interest Expense310.00K02.06M543.00K716.00K6.57M48.01M25.38M32.67M31.57M728.00K3.70M4.34M4.46M4.28M6.02M8.73M17.62M15.49M16.94M17.19M14.97M21.66M15.26M
Interest Expense % of Total Revenue0.11%0.00%0.49%0.11%0.12%0.92%6.17%3.45%4.43%4.55%0.11%0.54%0.61%0.56%0.47%0.54%0.64%1.10%1.09%0.84%0.74%0.62%0.86%0.59%

Balance Sheet

Currency: CHF2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets251.04M351.79M404.53M536.28M646.95M946.48M728.25M802.94M853.89M811.26M772.61M1.02B1.16B1.05B1.09B1.68B1.86B2.39B2.55B2.97B3.37B3.32B3.62B3.82B
Total Liabilities61.06M95.82M92.91M116.29M143.37M322.99M190.59M167.52M158.26M140.15M141.40M388.36M423.94M441.33M456.24M608.45M660.25M1.02B1.34B1.47B1.52B1.48B1.58B1.65B
Total Equity188.91M254.09M309.50M418.48M503.57M619.68M537.66M635.42M695.63M671.12M631.21M631.38M736.84M604.97M633.68M1.07B1.20B1.36B1.20B1.50B1.85B1.84B2.04B2.16B
Cash70.30M103.36M107.11M94.19M171.81M190.19M147.90M261.57M349.60M377.05M140.50M383.80M459.42M318.30M164.02M281.82M278.67M260.21M632.20M880.42M696.10M410.31M375.49M475.43M
Total Debt14.20M29.20M---137.42M50.00M---47.00K199.34M199.44M199.57M199.79M201.76M201.91M455.50M722.05M706.57M701.60M445.41M460.90M650.72M
Net Debt-56.10M-74.16M-107.11M-94.19M-171.81M-52.77M-97.90M-261.57M-349.60M-377.05M-140.46M-184.45M-259.98M-118.73M35.77M-80.05M-76.76M195.29M89.85M-173.85M5.49M35.10M85.41M175.29M

Cash Flow

Currency: CHF2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow69.66M118.03M144.20M144.49M174.58M223.15M198.76M245.14M175.84M140.22M114.56M151.49M146.16M185.60M184.74M217.29M277.10M380.27M377.41M561.94M416.38M503.95M483.39M505.42M
Investing Cash Flow-22.80M-84.84M-64.81M-121.07M-43.33M-245.48M-89.82M-31.13M-22.40M-25.62M-285.55M-62.59M-25.93M-48.10M-83.39M-292.85M-199.33M-286.30M-145.64M-185.20M-449.84M-349.33M-352.62M-275.35M
Financing Cash Flow-10.76M-414.00K-75.22M-36.85M-54.02M40.11M-135.66M-96.36M-56.14M-89.85M-63.49M155.65M-44.99M-274.67M-257.05M192.57M-77.56M-109.12M153.33M-122.90M-140.35M-424.40M-169.06M-105.95M
Capital Expenditure13.59M26.42M65.52M52.48M37.46M37.66M55.38M31.35M22.14M19.42M19.43M10.91M16.88M32.06M39.17M66.55M92.92M149.86M82.07M120.97M195.43M189.43M167.77M175.63M
Free Cash Flow56.07M91.61M78.68M92.01M137.13M185.49M143.38M213.79M153.70M120.79M95.13M140.58M129.28M153.53M145.57M150.74M184.18M230.41M295.34M440.97M220.94M316.61M315.62M329.78M
Dividends Paid9.29M17.43M48.08M31.14M39.04M46.73M58.41M58.41M58.69M58.76M58.03M57.85M58.26M58.56M63.15M65.14M75.12M83.13M91.23M91.38M107.43M127.44M135.43M151.34M
FCF to OCF80.49%77.62%54.56%63.68%78.55%83.12%72.14%87.21%87.41%86.15%83.04%92.80%88.45%82.72%78.80%69.37%66.47%60.59%78.25%78.47%53.06%62.83%65.29%65.25%
Dividend Paid to FCF16.56%19.03%61.10%33.84%28.47%25.19%40.74%27.32%38.18%48.65%61.00%41.15%45.07%38.14%43.38%43.21%40.79%36.08%30.89%20.72%48.62%40.25%42.91%45.89%

Earnings

Report DateAug 12, 2005Aug 16, 2011Feb 22, 2012Feb 21, 2013Apr 30, 2015Aug 20, 2015Oct 29, 2015Feb 25, 2016Aug 23, 2016Oct 27, 2016Feb 15, 2017Apr 27, 2017Aug 17, 2017Oct 26, 2017Feb 15, 2018May 1, 2018Aug 14, 2018Oct 30, 2018Feb 19, 2019Apr 30, 2019Aug 14, 2019Oct 29, 2019Feb 18, 2020Apr 30, 2020Aug 21, 2020Oct 28, 2020Feb 16, 2021Apr 29, 2021Aug 12, 2021Oct 28, 2021Feb 15, 2022Apr 28, 2022Aug 16, 2022Nov 2, 2022Feb 21, 2023May 3, 2023Aug 15, 2023Oct 31, 2023Feb 27, 2024Apr 30, 2024Aug 14, 2024Oct 29, 2024Feb 19, 2025Apr 30, 2025Aug 13, 2025Oct 29, 2025Feb 18, 2026Oct 28, 2026
EPS Estimate0.460.470.290.200.004.410.004.586.150.005.990.007.240.000.800.009.430.007.830.000.909.260.920.0012.770.008.850.009.870.0011.160.0015.540.0014.980.0016.640.0016.782.951.522.951.390.001.910.001.48-
EPS Actual0.440.150.080.070.000.000.000.000.000.000.000.009.080.000.240.008.160.009.020.008.970.0010.080.00-5.890.0011.560.0010.870.0013.940.001.660.001.060.000.000.000.002.950.002.951.200.001.660.001.33-
Surprise-4.35%-68.09%-72.41%-65.00%--100.00%--100.00%-100.00%--100.00%-25.41%--70.00%--13.47%-15.20%-896.67%-100.00%995.65%--146.12%-30.62%-10.13%-24.91%--89.32%--92.92%--100.00%--100.00%0.00%-100.00%0.00%-13.67%--13.09%--10.14%-
Timing-After-hoursAfter-hoursPre-market--------------------------Pre-market-Pre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hours-After-hours----After-hours-After-hoursAfter-hours

Key Statistics & Ratios

Market Cap14.83B
Enterprise Value15.60B
Trailing P/E40.26
Forward P/E26.11
PEG Ratio1.25
Price / Sales5.62
Price / Book6.80
EPS2.31
Book Value14.35
Revenue (TTM)2.64B
Gross Profit (TTM)1.83B
EBITDA750.60M
Profit Margin14.00%
Operating Margin25.14%
Return on Equity17.05%
Return on Assets10.99%
Shares Outstanding159.45M
Shares Float107.62M
Beta1.36
Dividend Yield1.09%
Dividend Rate1.00
Payout Ratio75.19%

Dividends

20261×
1.00Apr 21, 2026
20251×
0.95Apr 14, 2025
20241×
0.85Apr 16, 2024
20231×
0.80Apr 11, 2023
20221×
0.68Apr 7, 2022
20211×
0.57Apr 13, 2021
20201×
0.57Apr 9, 2020
20191×
0.53Apr 9, 2019
20181×
0.47Apr 10, 2018
20171×
0.42Apr 11, 2017
20161×
0.40Apr 12, 2016
20151×
0.38Apr 14, 2015
20141×
0.38Apr 15, 2014
20131×
0.38Apr 9, 2013
20121×
0.38Apr 10, 2012
20111×
0.38Mar 22, 2011
20101×
0.38Mar 31, 2010
20091×
0.38Mar 25, 2009
20081×
0.38Apr 2, 2008
20071×
0.30Apr 4, 2007
20061×
0.25Mar 31, 2006
20051×
0.20Mar 31, 2005
20041×
0.15Apr 30, 2004
20031×
0.11Apr 30, 2003

Stock Splits

  • Apr 20, 202210:1
  • Jul 20, 200120:1